Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,661 INR | -0.50% | +0.05% | -1.19% |
02-09 | India's Zydus Lifesciences beats Q3 profit estimates; approves shares buyback | RE |
02-08 | Transcript : Zydus Wellness Limited, Q3 2024 Earnings Call, Feb 08, 2024 |
Sales 2024 * | 23.19B 278M 379M | Sales 2025 * | 26.27B 315M 430M | Capitalization | 106B 1.27B 1.74B |
---|---|---|---|---|---|
Net income 2024 * | 2.9B 34.83M 47.51M | Net income 2025 * | 3.95B 47.35M 64.59M | EV / Sales 2024 * | 4.55 x |
Net cash position 2024 * | 566M 6.79M 9.26M | Net cash position 2025 * | 2.8B 33.54M 45.74M | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
35.7
x | P/E ratio 2025 * |
26.8
x | Employees | 975 |
Yield 2024 * |
0.44% | Yield 2025 * |
0.62% | Free-Float | 20.12% |
Latest transcript on Zydus Wellness Limited
1 day | -0.50% | ||
1 week | +0.05% | ||
Current month | +12.57% | ||
1 month | +10.24% | ||
3 months | +4.14% | ||
6 months | +7.79% | ||
Current year | -1.19% |
Managers | Title | Age | Since |
---|---|---|---|
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 15-05-13 |
Umesh V. Parikh
DFI | Director of Finance/CFO | - | 18-02-06 |
Compliance Officer | - | 22-07-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 09-04-26 | |
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 15-05-13 |
Director/Board Member | 50 | 19-03-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1,661 | -0.50% | 5 656 |
24-04-26 | 1,669 | -0.12% | 32,166 |
24-04-25 | 1,671 | +1.20% | 101,318 |
24-04-24 | 1,652 | +1.00% | 13,035 |
24-04-23 | 1,635 | -1.51% | 22,097 |
Delayed Quote NSE India S.E., April 29, 2024 at 01:13 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.93% | 266B | |
-2.51% | 94.98B | |
+3.19% | 46.39B | |
+8.74% | 39.99B | |
-0.65% | 39.95B | |
-0.15% | 38.02B | |
-16.78% | 30.16B | |
-5.51% | 28.72B | |
+11.32% | 24.54B |
- Stock Market
- Equities
- ZYDUSWELL Stock
- ZYDUSWELL Stock